EAM
Erste Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.69M | Sell |
48,796
-1,892
| -4% | -$104K | 0.02% | 359 |
|
|
2025
Q1 | $3.52M | Sell |
50,688
-19,247
| -28% | -$1.34M | 0.05% | 253 |
|
|
2024
Q4 | $4.58M | Sell |
69,935
-620,000
| -90% | -$40.6M | 0.06% | 245 |
|
|
2024
Q3 | $48.5M | Sell |
689,935
-4,190
| -0.6% | -$295K | 0.58% | 46 |
|
|
2024
Q2 | $57.3M | Buy |
694,125
+80,000
| +13% | +$6.6M | 0.76% | 35 |
|
|
2024
Q1 | $53.8M | Sell |
614,125
-20,000
| -3% | -$1.75M | 0.73% | 39 |
|
|
2023
Q4 | $61.2M | Buy |
634,125
+26,000
| +4% | +$2.51M | 0.9% | 23 |
|
|
2023
Q3 | $53.9M | Buy |
608,125
+18,533
| +3% | +$1.64M | 0.93% | 18 |
|
|
2023
Q2 | $51.3M | Buy |
589,592
+348
| +0.1% | +$30.3K | 0.9% | 21 |
|
|
2023
Q1 | $57.1M | Buy |
589,244
+75,030
| +15% | +$7.27M | 1.09% | 13 |
|
|
2022
Q4 | $53.1M | Sell |
514,214
-1,020
| -0.2% | -$105K | 1.12% | 13 |
|
|
2022
Q3 | $43.7M | Buy |
515,234
+3,964
| +0.8% | +$336K | 0.98% | 18 |
|
|
2022
Q2 | $42.5M | Sell |
511,270
-50,380
| -9% | -$4.18M | 0.94% | 19 |
|
|
2022
Q1 | $43.4M | Sell |
561,650
-46,650
| -8% | -$3.6M | 0.83% | 30 |
|
|
2021
Q4 | $54.2M | Hold |
608,300
| – | – | 0.98% | 16 |
|
|
2021
Q3 | $47M | Buy |
608,300
+3,400
| +0.6% | +$263K | 0.93% | 21 |
|
|
2021
Q2 | $50.5M | Hold |
604,900
| – | – | 1.01% | 18 |
|
|
2021
Q1 | $45.6M | Buy |
604,900
+71,360
| +13% | +$5.38M | 1.12% | 18 |
|
|
2020
Q4 | $46.3M | Buy |
533,540
+70,800
| +15% | +$6.15M | 1.28% | 11 |
|
|
2020
Q3 | $35.2M | Buy |
462,740
+84,900
| +22% | +$6.46M | 1.2% | 12 |
|
|
2020
Q2 | $46.5M | Buy |
377,840
+49,640
| +15% | +$6.1M | 1.85% | 5 |
|
|
2020
Q1 | $27.5M | Sell |
328,200
-111,700
| -25% | -$9.37M | 1.6% | 8 |
|
|
2019
Q4 | $37.3M | Buy |
439,900
+32,100
| +8% | +$2.72M | 1.65% | 6 |
|
|
2019
Q3 | $27.6M | Buy |
407,800
+1,520
| +0.4% | +$103K | 1.47% | 14 |
|
|
2019
Q2 | $34.6M | Buy |
406,280
+54,300
| +15% | +$4.63M | 1.84% | 6 |
|
|
2019
Q1 | $31.2M | Buy |
351,980
+140
| +0% | +$12.4K | 1.75% | 9 |
|
|
2018
Q4 | $29.4M | Buy |
+351,840
| New | +$29.4M | 1.98% | 8 |
|